SCHEMBL8517902

SCHEMBL8517902

[O-][n+]1c(NCC(F)(F)c2ccccn2)ncc(Cl)c1CCNCc1n[nH]c2ccc(Cl)cc12

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F2 P00734 20/20 0.40
F10 P00742 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8523803 0.83 F2 (0.38) F2F10
SCHEMBL8515805 0.79 F2 (0.40) F2F10
SCHEMBL8524364 0.77 F2 (0.38) F2F10
SCHEMBL8292389 0.75 F2 (0.54) F2
SCHEMBL8524852 0.74 F2 (0.37) F2
SCHEMBL8519327 0.69 PIK3CA (0.39) F2
SCHEMBL14508582 0.66 F2 (0.58) F2
SCHEMBL14508581 0.65 F2 (0.54) F2F10
SCHEMBL5477880 0.65 F2 (0.52) F2
SCHEMBL8292395 0.62 F2 (0.51) F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1674464-A1 Novel thrombin inhibitors Santhera Pharmaceuticals (Schweiz) GmbH (CH) 2006-06-28 EP disclosed